James Parsons
Förmögenhet: 651 069 $ per 2026-06-30
Förmögenhet: 651 069 $ per 2026-06-30
Mr. James T.
Parsons, CPA, is a Chief Financial Officer & Director at Sernova Biotherapeutics, Inc. and a Chairman at DiaMedica Therapeutics, Inc. He is on the Board of Directors at Oncolytics Biotech, Inc. and Sernova Biotherapeutics, Inc. Mr. Parsons was previously employed as a Chief Financial & Accounting Officer by Trillium Therapeutics, Inc., a Chief Financial Officer by Amorfix Life Sciences Ltd., a Chief Financial Officer & Secretary by Trillium Therapeutics, Inc. /Old/, a Vice President-Finance & Administration by Lorus Therapeutics, Inc., and a Controller & Assistant Treasurer by Timminco Ltd. He also served on the board at YM BioSciences, Inc. He received his graduate degree from The University of Waterloo.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-06-01 | 75 854 ( -.--% ) | 534 012 $ | 2026-06-30 | |
| 2026-04-14 | 614 605 ( 0,16 % ) | 61 461 $ | 2026-06-30 | |
ONCOLYTICS BIOTECH INC. 0,04 % | 2026-06-01 | 41 849 ( 0,04 % ) | 39 757 $ | 2026-06-30 |
| 2026-06-01 | 2 250 ( 0 % ) | 15 840 $ | 2026-06-30 |
| Företag | Position | Start |
|---|---|---|
| DIAMEDICA THERAPEUTICS INC. | Ordförande | 2025-01-01 |
| SERNOVA BIOTHERAPEUTICS INC | Finansdirektör/CFO | 2024-10-11 |
| ONCOLYTICS BIOTECH INC. | Direktör/Styrelseledamot | 2022-06-16 |
| Företag | Position | Slut |
|---|---|---|
| TRILLIUM THERAPEUTICS | Finansdirektör/CFO | 2021-11-17 |
Trillium Therapeutics, Inc. /Old/
Trillium Therapeutics, Inc. /Old/ Miscellaneous Commercial ServicesCommercial Services Provides research and development of pharmaceuticals | Finansdirektör/CFO | 2014-06-06 |
| PROMIS NEUROSCIENCES, INC. | Finansdirektör/CFO | 2010-10-20 |
| APTOSE BIOSCIENCES INC. | Finansdirektör/CFO | 2003-01-01 |
| TIMMINCO LIMITED | Comptroller/Controller/Revisor | 2000-01-01 |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 10 |
|---|---|
Aptose Biosciences, Inc.
Aptose Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Discovers, research and develops anticancer therapies with high safety profiles | Health Technology |
Oncolytics Biotech, Inc.
Oncolytics Biotech, Inc. BiotechnologyHealth Technology Discovers and develops pharmaceutical products for the treatment of cancers | Health Technology |
YM BioSciences, Inc.
YM BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Produces cancer-related drug products | Health Technology |
Sernova Biotherapeutics, Inc.
Sernova Biotherapeutics, Inc. BiotechnologyHealth Technology Develops life science products | Health Technology |
Timminco Ltd.
Timminco Ltd. Metal FabricationProducer Manufacturing Manufactures specialty magnesium, calcium and strontium alloys | Producer Manufacturing |
Trillium Therapeutics, Inc.
Trillium Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Researches, develops and manufactures medicines & therapies for cancer | Health Technology |
DiaMedica Therapeutics, Inc.
DiaMedica Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that engages in development and commercialization of therapeutic treatments from novel recombinant proteins | Health Technology |
ProMIS Neurosciences, Inc.
ProMIS Neurosciences, Inc. BiotechnologyHealth Technology Discovers and develops precision medicine solutions for the treatment of neurodegenerative & misfolded protein diseases | Health Technology |
The University of Waterloo
The University of Waterloo Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Trillium Therapeutics, Inc. /Old/
Trillium Therapeutics, Inc. /Old/ Miscellaneous Commercial ServicesCommercial Services Provides research and development of pharmaceuticals | Commercial Services |
Välj din utgåva
All finansiell information anpassad till den nationella nivån